GHDX - Genomic Health, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Net Income25,677-3,857-13,919-33,308
Operating Activities, Cash Flows Provided By or Used In
Depreciation8,8698,5596,4336,689
Adjustments To Net Income26,47618,91718,71115,335
Changes In Accounts Receivables-6,2474,0181,985-2,248
Changes In Liabilities8,374-2,187-5,0101,045
Changes In Inventories----
Changes In Other Operating Activities9,6131,2812,750276
Total Cash Flow From Operating Activities76,56230,60213,450-11,831
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures-10,076-13,276-19,786-23,483
Investments-71,084-27,2926,75229,696
Other Cash flows from Investing Activities----
Total Cash Flows From Investing Activities-81,105-42,558-19,1266,283
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid----
Sale Purchase of Stock----
Net Borrowings----
Other Cash Flows from Financing Activities----
Total Cash Flows From Financing Activities20,75217,07913,5418,355
Effect Of Exchange Rate Changes----
Change In Cash and Cash Equivalents16,2095,1237,8652,807